AgomAb Therapeutics NV (AGMB) insider trading in the last 6 months
3 insiders bought $620K. No sales.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Who files at AgomAb Therapeutics NV
Cluster buys at AGMB
3 insiders bought AGMB in the last 6 months: David R. Epstein, Tim Jasper Knotnerus, and Pierre Thadee Victor Kemula.
Questions about AGMB's insider trades
Are AGMB insiders buying or selling?
3 insiders bought $620K across 18 filings in the last 6 months. No open-market sales on record. The newest filing: David R. Epstein, Director, bought $28K on Nov 17, 2026. 3 insiders bought AGMB in the last 6 months: David R. Epstein, Tim Jasper Knotnerus, and Pierre Thadee Victor Kemula.
Who are AGMB's biggest insider sellers?
No AGMB insider sold shares on the open market in the last 6 months, as filed on Form 4.
When did an AGMB insider last buy?
David R. Epstein, Director, bought AGMB shares ($28K) on Nov 17, 2026, filed Nov 19, 2026, the newest insider buy on record.
AgomAb Therapeutics NV's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech. AGMB is on this week's insider buys.